Finance

Beta
Lists
SDPC:IDX
Millennium Pharmacon Internationl Tbk PT
IDR 179.00
-2.72%
(-5.00) 1D
Jun 4, 4:09:35 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SDPC...
Open
IDR 184
High
IDR 184
Low
IDR 176
Mkt. cap
228.05B
Avg. vol.
307.75K
Volume
88.80K
Dividend
1.68%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 8, 2026
P/E ratio
5.96
52-wk high
IDR 214
52-wk low
IDR 122
EPS
IDR 30
Shares outstanding
1.27B
No. of employees
1K
Open
IDR 184
High
IDR 184
Low
IDR 176
Mkt. cap
228.05B
Avg. vol.
307.75K
Volume
88.80K
Dividend
1.68%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 8, 2026
P/E ratio
5.96
52-wk high
IDR 214
52-wk low
IDR 122
EPS
IDR 30
Shares outstanding
1.27B
No. of employees
1K
News stories
From sources across the web
About Millennium Pharmacon Internationl Tbk PT
CEO-
Employees1.2K
Founded1952
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
962.50B
1.06T
1.11T
1.02T
Cost of goods sold
879.67B
975.40B
1.00T
930.34B
Cost of revenue
879.67B
975.40B
1.00T
930.34B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.64B
56.24B
61.14B
58.04B
Operating expense
58.86B
59.42B
71.31B
59.44B
Total operating expenses
938.53B
1.03T
1.07T
989.78B
Operating income
23.96B
24.66B
33.66B
28.19B
Other non operating income
-
-
-
-
EBT including unusual items
7.07B
7.31B
21.04B
13.11B
EBT excluding unusual items
7.07B
7.31B
21.04B
13.11B
Income tax expense
661.66M
3.67B
2.95B
3.00B
Effective tax rate
9.36%
50.18%
14.05%
22.91%
Other operating expenses
1.23B
3.18B
10.17B
1.40B
Net income
6.41B
3.64B
18.08B
10.10B
Net profit margin
0.67%
0.34%
1.63%
0.99%
Earnings per share
-
-
-
-
Interest and investment income
186.31M
41.47M
45.33M
37.63M
Interest expense
-17.08B
-17.40B
-12.67B
-15.12B
Net interest expenses
-16.89B
-17.36B
-12.63B
-15.09B
Depreciation and amortization charges
-
-
-
-
EBITDA
26.14B
27.16B
36.39B
29.93B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more